The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ANAB FINANCIAL STATEMENTS

AnaptysBio Inc — balance sheet, income statement and cash flow trends

ANABAnaptysBio Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M202120222023202420252026

Profit Funnel

Q1 2026 · TTM
Revenue232.4 M $Gross Profit270.5 M $ · 116%Operating Income40.8 M $ · 18%Pre-tax Income-26.6 M $ · -11%Net Income to Owners-26.8 M $ · -12%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue232.4 M $+107.7%
Gross Profit270.5 M $—
Operating Income40.8 M $—
EBITDA58.5 M $—
Net Income to Owners-26.8 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q1 2026
Total Assets329.7 M
  • Equity12.7 M $4%
  • Current Liabilities41.7 M $13%
  • Long-term Liabilities275.2 M $83%

Key Figures

YoY change
Total Assets329.7 M $-21.9%
Total Liabilities316.9 M $-18.3%
Total Equity12.7 M $-62.5%
Cash & ST Investments286.5 M $-15.7%
Total Debt277.4 M $+1,680.8%
Net Debt28.9 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-150 M-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q1 2026 · TTM
0100 M200 M4.5 M $Operating248.2 M $Investing-102.8 M $Financing149.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow4.5 M $—
Capital Expenditures69 K $-81.1%
Free Cash Flow4.4 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ANAB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.